🇺🇸 Acumen Pharmaceuticals, Inc.ABOS
Get Acumen Pharmaceuticals, Inc. filings on Telegram the moment they are published.
Follow Acumen Pharmaceuticals, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 7.01, 8.01, 9.01
Overview: Phase 2 ALTITUDE-AD trial of sabirnetug failed to meet its primary endpoint for early Alzheimer’s disease, leading the company to cease clinical development.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest